Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiotensin II Type 1 Receptor Blockers”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Not applicableEnded earlyNCT00338091
What this trial is testing

Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency

Who this might be right for
Renal Insufficiency,ChronicDisease ProgressionProteinuria+3 more
Southern Medical University, China
Post-approval studies (Phase 4)UnknownNCT00235287
What this trial is testing

Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease

Who this might be right for
Kidney Failure, ChronicCardiovascular Diseases
Herlev Hospital 60
Not applicableStudy completedNCT04318418
What this trial is testing

ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19

Who this might be right for
COVID-19
Neuromed IRCCS 3,400
Not applicableUnknownNCT00565396
What this trial is testing

Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3

Who this might be right for
Chronic Kidney InsufficiencyAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor Blockers+1 more
Shanghai Municipal Health Bureau 400
Large-scale testing (Phase 3)Study completedNCT00265642
What this trial is testing

Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
ANRS, Emerging Infectious Diseases 166
Post-approval studies (Phase 4)Study completedNCT00162955
What this trial is testing

Prevention of CHOP-induced Chronic Cardiotoxicity

Who this might be right for
Non-Hodgkin's Lymphoma
Osaka City University 150
Testing effectiveness (Phase 2)Study completedNCT02944734
What this trial is testing

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Shin Poong Pharmaceutical Co. Ltd. 392
Not applicableStudy completedNCT04954560
What this trial is testing

Effect of Losartan or Eprosartan on Fructose Hyperuricemia

Who this might be right for
Uric Acid Concentration, Serum, Quantitative Trait Locus 7
Medical University of Lodz 16
Testing effectiveness (Phase 2)Ended earlyNCT02085265
What this trial is testing

Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Sunnybrook Health Sciences Centre 23
Not applicableUnknownNCT01444833
What this trial is testing

Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker

Who this might be right for
Hypertension
Slovak Academy of Sciences 35
Not applicableStudy completedNCT00774904
What this trial is testing

Adiponectin and Insulin Resistance in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Xi'an Jiaotong University 80
Large-scale testing (Phase 3)Study completedNCT03066804
What this trial is testing

A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Novartis Pharmaceuticals 2,572
Post-approval studies (Phase 4)UnknownNCT00144144
What this trial is testing

A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes

Who this might be right for
HypertensionDiabetes Mellitus, Type 2
Advanced-J 300
Not applicableUnknownNCT04510623
What this trial is testing

Host Response Mediators in Coronavirus (COVID-19) Infection

Who this might be right for
COVID-19SARS-CoV2
University of British Columbia 500
Post-approval studies (Phase 4)Study completedNCT00237588
What this trial is testing

Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

Who this might be right for
Hypertension
Ullevaal University Hospital 25
Not applicableStudy completedNCT00561704
What this trial is testing

Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

Who this might be right for
ObeseType 2 DiabetesDiabetic Nephropathy+2 more
Shanghai Jiao Tong University School of Medicine 80
Large-scale testing (Phase 3)Study completedNCT00141453
What this trial is testing

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Who this might be right for
Diabetic NephropathyType 2 Diabetes MellitusProteinuria
Daiichi Sankyo Co., Ltd. 577
Large-scale testing (Phase 3)Ended earlyNCT00763893
What this trial is testing

Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome

Who this might be right for
Marfan Syndrome
Assistance Publique - Hôpitaux de Paris 303
Post-approval studies (Phase 4)Study completedNCT00890591
What this trial is testing

Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 144
Not applicableStudy completedNCT01091961
What this trial is testing

Study of Preoperative Management of Angiotensin Converting Enzyme Inhibitor (ACEi) and Angiotensin Receptor Blocker (ARB) Medications

Who this might be right for
Hypertension
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 200
Load More Results